CITED2 in Breast Carcinoma as a Potent Prognostic Predictor Associated With Proliferation, Migration, and Chemoresistance

CITED2 plays important roles in the progression and chemoresistance of breast carcinoma and CITED2 status is a potent prognostic factor in breast cancer patients.

 Cancer Science

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.